Dr. Brandman aims to expand the existing care models for liver transplant patients with alcohol related liver disease and nonalcoholic fatty liver disease, as well as to improve outreach efforts to patients with advanced liver disease.
Dr. Johnson has mentored investigators working on some of the world's most virulent infectious diseases, from HIV/AIDS to malaria, hepatitis, leptospirosis, schistosomiasis, tuberculosis, leishmaniasis, and cryptosporidiosis.
The WDOM’s Research Retreat will be held on Wednesday, November 30, 2022. Proceedings begin at the Belfer Research Building and culminate with a keynote speaker in the Uris Auditorium.
Dr. Glesby will develop innovative new efforts to enhance the professional growth of faculty at all levels, and focus on positioning faculty for promotion and play a critical role in the integration of faculty from our other campuses.
Paige will direct administrative and business activities within the department, including finance, accounting, research administration, clinical operations, capital planning, academic appointments, and education.
In his last presentation at Medicine Grand Rounds, Dr. Hollenberg provided a slideshow of the many advances within WDOM. Dr. Hollenberg stepped down as Chair of the WDOM as of September 30, 2022.
Dr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director.
An expert in the field of endocrinology, Dr. Mahler was beloved by patients, trainees, and colleagues alike.
WDOM is pleased to announce our Annual Report, covering activities spanning calendar year 2021. The department remains dedicated to its missions centered around clinical care, health equity, biomedical research, and education.
The WDOM congratulates its faculty who received Weill Cornell Medicine’s 2022 Excellence in Medical Education Awards. These awards honor educators for their outstanding contributions to the Weill Cornell Medicine medical education program.
